Quoted Micro 17 June 2024

AQUIS STOCK EXCHANGE Samarkand (SMK) has sold its probiotic brand of Probio7 for £1.3m with an initial cash payment of £1.1m. This will provide working capital for the company’s other healthcare brands. Unsecured loans made by the directors to finance the acquisition of Optimised Energetics will be repaid. Skin treatments developer Incanthera (INC) has moved […]